HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis-Reference-Cited by-同舟云学术

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

Published:2023-11-29 Issue:12 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tunnicliffe David J¹²,Palmer Suetonia C³,Cashmore Brydee A¹²,Saglimbene Valeria M¹²⁴,Krishnasamy Rathika⁵,Lambert Kelly⁶,Johnson David W⁷⁸⁹,Craig Jonathan C¹¹⁰¹¹,Strippoli Giovanni FM⁴¹⁰

Affiliation:

1. Sydney School of Public Health; The University of Sydney; Sydney Australia

2. Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

3. Department of Medicine; University of Otago Christchurch; Christchurch New Zealand

4. Department of Emergency and Organ Transplantation; University of Bari; Bari Italy

5. Renal Unit; Sunshine Coast University Hospital; Birtinya Australia

6. School of Medicine; University of Wollongong; Wollongong Australia

7. Department of Nephrology; Princess Alexandra Hospital; Woolloongabba Australia

8. Australasian Kidney Trials Network; The University of Queensland; Brisbane Australia

9. Translational Research Institute; Brisbane Australia

10. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

11. College of Medicine and Public Health; Flinders University; Adelaide Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference456 articles.

1. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S;Ballantyne;Circulation,2001

2. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S);Lancet,1995

3. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study;Berg;Clinical Genetics,1997

4. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency;Chonchol;American Journal of Kidney Diseases,2007

5. Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study;Crea;Clinical Cardiology,2002